(0.23%) 5 143.25 points
(0.22%) 38 527 points
(0.32%) 17 902 points
(-0.45%) $83.47
(1.98%) $1.961
(-0.02%) $2 346.70
(0.28%) $27.61
(0.84%) $929.85
(-0.22%) $0.933
(-0.33%) $10.99
(-0.30%) $0.798
(1.16%) $92.94
0.10% INR 1 634.75
Live Chart Being Loaded With Signals
Poly Medicure Limited manufactures and sells medical devices. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I...
Stats | |
---|---|
Today's Volume | 27 777.00 |
Average Volume | 88 459.00 |
Market Cap | 156.89B |
EPS | INR0 ( 2024-02-02 ) |
Next earnings date | ( INR0 ) 2024-05-06 |
Last Dividend | INR3.00 ( 2023-09-21 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 62.95 |
ATR14 | INR0.911 (0.06%) |
Volume Correlation
Poly Medicure Limited Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Poly Medicure Limited Correlation - Currency/Commodity
Poly Medicure Limited Financials
Annual | 2022 |
Revenue: | INR11.15B |
Gross Profit: | INR7.09B (63.61 %) |
EPS: | INR18.69 |
FY | 2022 |
Revenue: | INR11.15B |
Gross Profit: | INR7.09B (63.61 %) |
EPS: | INR18.69 |
FY | 2022 |
Revenue: | INR9.17B |
Gross Profit: | INR4.84B (52.75 %) |
EPS: | INR15.28 |
FY | 2021 |
Revenue: | INR7.75B |
Gross Profit: | INR4.39B (56.59 %) |
EPS: | INR15.25 |
Financial Reports:
No articles found.
Poly Medicure Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR2.50 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR3.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.375 | 2012-09-13 |
Last Dividend | INR3.00 | 2023-09-21 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 15 | -- |
Total Paid Out | INR20.13 | -- |
Avg. Dividend % Per Year | 0.27% | -- |
Score | 2.15 | -- |
Div. Sustainability Score | 4.15 | |
Div.Growth Potential Score | 5.12 | |
Div. Directional Score | 4.63 | -- |
Year | Amount | Yield |
---|---|---|
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR2.00 | 0.80% |
2019 | INR2.00 | 0.90% |
2020 | INR2.00 | 0.92% |
2021 | INR2.50 | 0.49% |
2022 | INR2.50 | 0.26% |
2023 | INR3.00 | 0.33% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
RBLBANK.NS | Dividend Junior | 2023-08-18 | Sporadic | 8 | 0.25% | |
KOVAI.NS | Dividend Junior | 2023-08-10 | Annually | 4 | 0.17% | |
EXIDEIND.NS | Dividend Junior | 2023-08-01 | Annually | 22 | 0.76% | |
AMIORG.NS | Dividend Junior | 2023-09-18 | Annually | 3 | 0.15% | |
TALBROAUTO.NS | Dividend Junior | 2023-09-15 | Annually | 18 | 0.48% | |
NGIL.NS | No Dividend Player | 2023-09-21 | Annually | 4 | 0.08% | |
IGPL.NS | Dividend Junior | 2023-08-17 | Sporadic | 18 | 1.12% | |
CHEMFAB.NS | Dividend Junior | 2023-08-22 | Sporadic | 7 | 0.32% | |
SAKSOFT.NS | Dividend Junior | 2023-08-07 | Semi-Annually | 20 | 0.56% | |
LUMAXIND.NS | Dividend Junior | 2023-08-10 | Annually | 23 | 1.26% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.191 | 1.500 | 6.19 | 9.28 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.193 | 1.500 | 8.97 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 30.75 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 10.15 | 2.00 | 6.62 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 10.15 | 2.00 | 4.93 | 9.85 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.650 | 1.000 | 2.50 | 2.50 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.248 | 1.000 | 7.04 | 7.04 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 4.15 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 63.65 | 1.000 | 3.67 | 0 | [1 - 100] |
returnOnEquityTTM | 0.193 | 2.50 | 9.34 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 10.15 | 2.00 | 6.62 | 9.85 | [0 - 30] |
dividendYielPercentageTTM | 0.182 | 1.500 | 5.45 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 10.15 | 2.00 | 6.62 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 323.55 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0746 | 1.000 | -0.634 | 0 | [0.1 - 0.5] |
Total Score | 5.12 |
Poly Medicure Limited
Poly Medicure Limited manufactures and sells medical devices. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also provides nasogastric and infant feeding tubes, gastro-duodenal feeding tubes, and umbilical catheters; urine collection bags, foley balloon catheters, irrigation sets, urine drainage catheters, and urine collection bags with measured volume meters; and endotracheal tubes, tracheostomy tubes, mucus extractors, ventilator circuits, bain circuits, catheter mounts, spinal needles, HME filters, and laryngeal mask airways. In addition, it offers oncology products; endo bronchial suction catheters, oxygen catheters, respiratory exercisers, nasal oxygen cannulas, oro-pharyngeal airways, variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, and aerosol therapy masks; and dialyzers, blood lines, dialysis systems, fistula needles, haemodialysis catheters, and peritoneal dialysis and transfusion sets. Further, it provides closed wound suction units, under water seal drainage systems, high pressure vacuum bottles, yankauer suction sets, and thoracic drainage catheters; blood collection tubes, safety blood collection sets, blood collection needles, erythrocyte sedimentation rate pipettes, and luer adaptors; blood bag systems; face protective shields, polymasks, and viral transport medium kits; and insulin syringes, sputum collectors, dry brushes, umbilical cord clamps, luer locks, cannula fixators, injection stoppers, luer lock injection sites, and universal caps. The company was incorporated in 1995 and is based in New Delhi, India.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators